Please login to the form below

Not currently logged in

Lexicon Pharmaceuticals

This page shows the latest Lexicon Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sanofi exits Zynquista alliance with Lexicon

Sanofi exits Zynquista alliance with Lexicon

Will pay $260m to end collaboration. Following rejection from the FDA earlier this year, Sanofi has agreed to pay Lexicon Pharmaceuticals $260m to end the alliance formed to develop and ... for demonstrating cardiovascular and renal benefits,” said

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    Licensor Acquired/ Licensee Acquirer. Product/ Technology. Deal Type. Headline ($m). Selexys Pharmaceuticals/ Novartis. ... Strategic alliance, options. 122.7 per. BMS/ Lexicon Pharmaceuticals. BMS-986176 for neutopathic pain (pc) plus other small

  • Deal Watch November 2015 Deal Watch November 2015

    Staying with diabetes, so strategically important, Sanofi put in place a collaboration with Lexicon Pharmaceuticals for sotagliflozin (LX4211), an oral treatment for type 1 and type 2 diabetes. ... 2, 075. Lexicon Pharmaceuticals. Sanofi. Collaboration,

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For multivalent MVA-BN Filovirus vaccine. 187. Lexicon Pharmaceuticals/Ipsen. Licence [B]. Telotristat etiprate in P3 for carcinoid syndrome.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...